1. South Korea Stocks

  2. •

    Process industries

  3. •

    Chemicals: specialty
Soulbrain Holdings Co., Ltd.

Soulbrain Holdings Co., Ltd.

KKRX:036830
37,200.00
KRW
-1,000.00
(-2.62%)
4,070.71EPS
1.84P/E
928.25BMarket Cap
Soulbrain Holdings Co., Ltd.
KRX:036830
(Korea Stock Exchange)

Recent

price

37,200.00

P/E

ratio

1.84

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
KRW
44,648.85
59,955.3
76,109.56
71,629.77
60,432.34
69,912.96
81,009.09
86,211.02
102,780.95
26,841.69
17,412.49
20,197.73
27,353.17
32,021.12
21,002.52
27,568.35
31,110.57
Revenue per Share
4,107.35
875.43
8,464.29
7,026.45
4,275.55
8,986.98
8,382.9
4,579.4
10,620.15
12,566.22
106,557
1,523
3,107
4,406
2,838
24,137
24,728.56
Basic EPS, GAAP
-889.78
-12,609.31
7,214.96
3,713.57
4,217.01
6,480.36
9,848.21
8,721.12
11,134.78
9,946.14
-1,787.48
-870.72
-2,554.3
-1,564.52
-219.72
599.29
-4,070.58
Free Cash Flow per Basic Share
452.06
542.58
582.78
678.3
809.79
810.3
904.38
1,093.84
1,267.1
1,356.55
1,059.26
- -
150.01
189.23
212.91
235.45
- -
Dividend per Share
26,327.44
28,130.6
37,552.94
43,814.81
47,412.22
55,456
62,598.02
68,752.11
77,772.52
89,111.38
50,119.86
52,436.14
55,592.14
59,882.32
63,962.81
84,875.4
87,285.68
Book Value per Share
26,006.39
26,551.03
34,869.14
41,921.34
45,981.82
54,026.63
61,109.93
67,759.67
76,616.63
88,476.76
46,539.77
45,166.16
46,512.92
51,866.45
55,844.35
81,763.28
84,162.24
Tangible Book Value per Share
8
8
9
9
9
9
9
9
9
9
14
21
21
21
21
20
20
Basic Weighted Avg Shares
358,476
481,273
663,610
635,106
538,585
627,917
722,521
775,598
963,425
250,381
235,745
417,195
565,106
661,555
433,749
556,647
626,878
Sales/Revenue/Turnover
14.22
11.94
16.13
13.93
8.92
16.09
14.55
13.63
17.03
7.85
7.03
13.1
13.01
19.19
7.33
1.59
2.16
Operating Margin (%)
14,944
20,225
30,012
33,512
39,272
42,349
49,149
50,890
48,594
52,096
38,490
27,566
32,955
37,377
47,704
57,051
57,040
Depreciation Expense
32,977
7,027
73,801
62,300
38,105
80,716
74,767
41,199
99,549
117,219
1,442,659
31,458
64,189
91,028
58,611
487,363
498,280
Net Income, GAAP
22.03
62.71
22.74
22.43
31.54
26.87
25.33
35.46
29.79
- -
18.27
39.66
7.85
19.02
51.62
19.5
15.08
Effective Tax Rate (%)
9.2
1.46
11.12
9.81
7.07
12.85
10.35
5.31
10.33
46.82
611.96
7.54
11.36
13.76
13.51
87.55
79.49
Profit Margin (%)
-15,006
-13,542
18,210
-9,628
30,288
-13,855
49,589
144,632
159,751
235,261
40,134
45,737
47,486
-4,147
-38,399
123,452
74,782
Working Capital
- -
69,820
31,888
6,951
3,384
11,264
16,817
5,833
15,165
10,055
100,795
116,144
147,125
112,461
7,261
25,275
25,032
LT Debt
226,393
225,240
333,355
388,255
422,008
492,664
560,973
649,859
733,788
841,669
1,036,086
1,104,442
1,181,785
1,264,180
1,495,160
1,947,609
1,998,707
Total Equity
14.86
5.81
18.51
13.96
6.29
12.22
11.1
8.88
13.58
- -
1.19
2.51
4.69
6.24
0.91
0.35
0.56
Return on Invested Capital (%)
12.73
2.75
18.01
13.68
8.23
14.19
11.24
5.54
11.93
- -
129
2.8
5.46
7.4
4.21
25.11
24.35
Return on Capital (%)
16.77
3.22
26.41
17.27
9.38
17.57
14.2
6.85
14.53
15.06
154.56
2.97
5.75
7.63
4.61
32.06
32.22
Return on Common Equity (%)

Capital Structure

KRW

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
412,602
214,004
210,574
LT Borrowings
16,330
12,282
12,117
LT Finance Leases
6,492
12,993
12,916
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
20
20
20
Market Capitalization
853,523
762,635
928,248

Working Capital

KRW

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
468,776
629,341
581,617
Cash, Cash Equivalents & STI
125,176
434,095
326,478
Accounts Receivable, Net
83,862
77,697
107,757
Inventories
109,810
93,075
111,404
Total Current Liabilities
578,334
505,889
506,835
Payables & Accruals
- -
- -
- -
ST Debt
412,602
214,004
210,574
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
14.95%
13.82%
30.26%
Free Cash Flow
-38.76%
-64.73%
-366.67%
Net Income, GAAP
198.18%
148.79%
731.52%
Sales/Revenue/Turnover
9.02%
24.68%
28.33%
Total Cash Common Dividend
- -
- -
8.12%

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
136,257
129,059
94,668
134,083
433,749
2025
126,342
169,414
140,897
140,247
556,647
2026
176,320
- -
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,113
2,411
382
-1,075.57
2,838
2025
567
1,079
3,475
19,131.85
24,137
2026
1,111
- -
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
212.91
2025
- -
- -
- -
- -
235.45
2026
- -
- -
- -
- -
- -
Similar Companies
Petkim Petrokimya Holding Anonim Sirketi (BIST:PETKM)
Albemarle Corporation (NYSE:ALB)
Linde plc (NASDAQ:LIN)
Gubre Fabrikalari T.A.S. (BIST:GUBRF)
Dow Inc. (NYSE:DOW)
IOL Chemicals & Pharmaceuticals Ltd. (NSE:IOLCP)
Business
Soulbrain Holdings Co., Ltd. develops, manufactures, and supplies core materials for the semiconductor, display, and secondary battery industries primarily in South Korea and internationally. The company offers chemical vapor deposition (CVD) and atomic layer deposition (ALD) materials, etchants and cleaning agents including hydrofluoric acid and buffered oxide etchants, chemical mechanical polishing (CMP) slurries, copper metalizing products; display materials such as organic materials, thin glasses, AMOLED glass scribes and cells, optical films, resin black matrixes for LCD color filters, and BOA/BCS negative organic insulators for LCD TFT; secondary battery materials including electrolytes and lead tabs; as well as LED process materials, solar cell materials, electric vehicle electronic materials, high purity phosphoric acid, biosensors, and cosmetics. Founded in 1986 and headquartered in Seongnam-si, South Korea, Soulbrain Holdings operates through subsidiaries including Soulbrain SLD Co., Ltd. for AMOLED glass scribing, probe cards, and cells; Soulbrain optos Co., Ltd. for optical films; Fect Co., Ltd. for fluorine compound etchants; Soulbrain RASA Co., Ltd. for high purity phosphoric acid; MC Solution Co., Ltd. for LCD materials; GENIC Co., Ltd. for cosmetics; Prowell Co., Ltd. for semiconductor equipment; Soulbrain MI Co., Ltd. for Li-ion battery electrolytes in the United States; overseas production entities in China, Malaysia, and Hungary; financial arms such as Soulbrain Savings Bank Co., Ltd. and NAU IB Capital Co., Ltd.; and diagnostics firms including ARK Diagnostics, Inc., PixCell Medical Technologies Ltd., and GeneChem Inc. In November 2025, Soulbrain Holdings partnered with ARCHIMED Diagnostics in a joint venture following ARCHIMED's acquisition of a 60% stake in ARK Diagnostics, Inc., where Soulbrain reinvested in a 40% stake to advance immunoassay technologies for therapeutic drug monitoring, drugs of abuse testing, immunodiagnostics, specialty diagnostics, and veterinary applications, valuing ARK at $428 million. The company maintains a diversified portfolio across chemicals, materials, bio-healthcare, and financial services with facilities in South Korea, the United States, China, Malaysia, Hungary, and Israel.